Orthofix Medical Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Orthofix Medical Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 575.00 shares, a 99.36% decline from fiscal 2021.
- Orthofix Medical Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2021 was 89.15K shares, a 2.54% increase from fiscal 2020.
- Orthofix Medical Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2020 was 86.94K shares, a 16.35% increase from fiscal 2019.
- Orthofix Medical Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2019 was 74.73K shares, a 25.88% decline from fiscal 2018.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2022-12-31 | 575.00 shares 10-K · filed 2023-03-06 | |
| 2021-12-31 | 89.15K shares 10-K · filed 2022-02-25 | |
| 2020-12-31 | 86.94K shares 10-K · filed 2021-02-26 | |
| 2019-12-31 | 74.73K shares 10-K · filed 2020-02-24 | |
| 2018-12-31 | 100.82K shares 10-K · filed 2019-02-25 | |
| 2017-12-31 | 152.03K shares 10-K · filed 2018-02-26 | |
| 2016-12-31 | 469.94K shares 10-K · filed 2017-02-27 | |
| 2015-12-31 | 93.18K shares 10-K · filed 2016-02-29 | |
| 2014-12-31 | 366.96K shares 10-K · filed 2015-04-29 | |
| 2013-12-31 | 79.95K shares 10-K/A · filed 2015-03-31 | |
| 2012-12-31 | 716.56K shares 10-K/A · filed 2014-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |